Categories AlphaGraphs, Earnings, Health Care
Earnings: Intuitive Surgical (ISRG) Q3 results exceed estimates
Intuitive Surgical Inc. (NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related disruption. However, the results topped the Street view.
The top-line dropped 4% annually to $1.08 billion during the three-month period, despite an increase in the flagship da Vinci procedures. At $2.77 per share, adjusted earnings were down 19% year-over-year.
Net income declined to $314 million or $2.60 per share from $397 million or $3.33 per share in the third quarter of 2019. During the quarter, operations were disrupted by the pandemic and procedure volumes remained below the normal levels.
Read management/analysts’ comments on Intuitive Surgical’s Q3 results
Shares of Intuitive Surgical closed Thursday’s regular session lower. The stock has gained 27% since the beginning of the year.
Most Popular
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the
Constellation Brands set to report Q3 2026 earnings. Here’s what to expect
Constellation Brands' (NYSE: STZ) performance across its portfolio has been under scrutiny recently as it navigates a challenging consumer environment marked by sluggish demand and competitive pressures. With the beer
Broadcom Stock: Valuation and margins under review amid AI tailwinds
Broadcom, Inc. (NASDAQ: AVGO) has emerged as a key AI infrastructure supplier, leveraging its expertise in custom AI accelerators, to expand beyond its legacy smartphone and storage chip businesses. However,
